Can kidney parenchyma metabolites serve as prognostic biomarkers for long-term kidney function after nephrectomy for renal cell carcinoma? A preliminary study

OBJECTIVE: Nephrectomy, the standard of care for localized renal cell carcinoma (RCC), may lead to kidney function loss. Our goal was to identify prognostic biomarkers of postoperative renal function using metabolomics. METHODS: Metabolomics data from benign kidney parenchyma were collected prospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenzweig, Barak, Recabal, Pedro, Gluck, Caroline, Coleman, Jonathan A, Susztak, Katalin, Hakimi, A Ari, Jaimes, Edgar A, Weiss, Robert H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894921/
https://www.ncbi.nlm.nih.gov/pubmed/35261758
http://dx.doi.org/10.1093/ckj/sfaa185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894921/
https://www.ncbi.nlm.nih.gov/pubmed/35261758
http://dx.doi.org/10.1093/ckj/sfaa185

Ejemplares similares